Biotech Values

[iwfal]

it was not statistically significant for increased survival for either CD54 upregulation (post/preprocessing) (p=0.395)

This is the interesting thing to me (I missed it in the statistical review) - it bears, again, on the credibility of Dendreon management, since Provost's data showed something substantially different, albeit for combined 9901/2a.